Influence of opioid-related side effects on disability, mood, and opioid misuse risk among patients with chronic pain in primary care

Robert N Jamison, Kathleen Dorado, Anna Mei, Robert R Edwards, Marc O Martel, Robert N Jamison, Kathleen Dorado, Anna Mei, Robert R Edwards, Marc O Martel

Abstract

Background: There is increasing concern among primary care practitioners about the use of opioids for chronic pain, including their adverse effects, but little attention has been given to how reports of side effects from prescription medication can contribute to outcomes among patients with chronic pain. The aim of this study was to investigate the impact of frequently reported side effects on mood, disability, and opioid misuse in patients with chronic pain prescribed opioids within primary care.

Methods: Two hundred (N = 200) patients with chronic pain taking opioids for pain were recruited into the study. All patients completed baseline measures and a monthly side effects checklist once a month for 6 months. Patients were divided evenly based on a median split of the number of endorsed side effects over 6 months. The subjects repeated the baseline measures at the end of the study period.

Results: Over time, reports of medication side effects tended to decrease, but differences in frequency of reported side effects from baseline to follow-up (6-month time) were not significant, and the order of the frequency of the reported side effects remained similar. Patients who reported significant medication-related adverse effects reported significantly greater activity interference, negative affect, and catastrophizing compared with those with fewer side effects (P < 0.01). In addition, those patients with pain who reported more side effects showed significantly higher scores on opioid misuse risk (P < 0.001).

Discussion: This study demonstrates the important role of monitoring medication-related side effects among patients with chronic pain who are prescribed opioid medication for pain within primary care.

Keywords: Chronic pain; Medication misuse; Opioids; Pain management; Primary care; Side effects.

Conflict of interest statement

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

References

    1. Adams NJ, Plane MB, Fleming MF, Mundt MP, Saunders LA, Stauffacher EA. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage 2001;22:791–6.
    1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosomatic Res 2002;52:69–77.
    1. Bruehl S, Burns JW, Passik SD, Gupta R, Buvanendran A, Chont M, Schuster E, Orlowska D, France CR. The contribution of differential opioid responsiveness to identification of opioid risk in chronic pain patients. J Pain 2015:16:666–75.
    1. Butler SF, Budman SH, Fernandez KC, Fanciullo GJ, Jamison RN. Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). J Addict Med 2009;3:66–73.
    1. Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, Jamison RN. Development and validation of the current opioid misuse measure. PAIN 2007;130:144–56.
    1. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. PAIN 2004;112:65–75.
    1. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain 2008;9:360–72.
    1. Caldwell JR, Hale ME, Boyd RE, Hague JM, Iwan T, Shi M, Lacouture PG. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999;26:862–9.
    1. Centers for Disease Control and Prevention. Prescription pain killer overdoses. Available at: . Accessed February 4, 2017.
    1. Cicero TJ, Shores CN, Paradis AG, Ellis MS. Source of drugs for prescription opioid analgesic abusers: a role for the Internet? Pain Med 2008;9:718–23.
    1. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129–38.
    1. Crombez G, Beirens K, Van Damme S, Eccleston C, Fontaine J. The unbearable lightness of somatisation: a systematic review of the concept of somatisation in empirical studies of pain. PAIN 2009;145:31–5.
    1. Department of Health and Human Services. National Pain Strategy. Available at . Accessed February 4, 2017.
    1. Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing, and depression in the rheumatic diseases. Natl Rev Rheumatol 2011;7:216–24.
    1. Edwards RR, Wasan AD, Michna E, Greenbaum S, Ross E, Jamison RN. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J Pain 2011;12:953–63.
    1. Evans CJ, Trudeau C, Mertzanis P, Marquis P, Pena BM, Wong J, Mayne T. Development and validation of the Pain Treatment Satisfaction Scale (PTSS): a patient satisfaction questionnaire for use in patients with chronic or acute pain. PAIN 2004;112:254–66.
    1. Fishman SM, Wilsey B, Yang J, Reisfield GM, Bandman TB, Borsook D. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage 2000;20:293–307.
    1. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589–94.
    1. Gilson AM, Joranson DE. Controlled substances and pain management: changes in knowledge and attitudes of state medical regulators. J Pain Symptom Manage 2001;21:227–37.
    1. Gregorian RS, Jr, Gasik A, Kwong WJ, Voeller S, Kavanagh S. Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians. J Pain 2010;11:1095–108.
    1. Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press, 2011.
    1. Jamison RN. Mastering chronic pain: a professional's guide to behavioral treatment. Sarasota, FL: Professional Resource Press, 1996.
    1. Jamison RN, Edwards RR, Lui X, Ross EL, Michna E, Warnick M, Wasan AD. Relationship of negative affect and outcome of an opioid therapy trial among low back pain patients. Pain Pract 2013;13:173–81.
    1. Jamison RN, Mao J. Opioid analgesics. Mayo Clin Proc 2015; 90:957–68.
    1. Jamison RN, Martel MO, Edwards RR, Qian J, Sheehan KA, Ross EL. Validation of a brief opioid compliance checklist for patients with chronic pain. J Pain 2014;15:1092–101.
    1. Jamison RN, Ross EL, Michna E, Chen LQ, Holcomb C, Wasan AD. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. PAIN 2010;150:390–400.
    1. Jamison RN, Scanlan E, Matthews ML, Jurcik DC, Ross EL. Attitudes of primary care practitioners in managing chronic pain patients prescribed opioids for pain: a prospective longitudinal controlled trial. Pain Med 2016;17:99–113.
    1. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic noncancer pain: systematic review of efficacy and safety. PAIN 2004;112:372–80.
    1. Martel MO, Finan PH, Dolman AJ, Subramanian S, Edwards RR, Wasan AJ, Jamison RN. Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study. PAIN 2015;156:1092–100.
    1. Miech R, Johnston L, O'Malley PM, Keyes KM, Heard K. Prescription opioids in adolescence and future opioid misuse. Pediatrics 2015;136:1169–77.
    1. National Conference of State Legislatures. Special report, prevention of prescription drug overdose and abuse. Available at . Accessed May 23, 2016.
    1. Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleeland CM, Haddox JD. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007;90:64–71.
    1. Sullivan MJ, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess 1995;7:524–32.
    1. Sullivan MJ, Stanish W, Waite H, Sullivan M, Tripp DA. Catastrophizing, pain, and disability in patients with soft-tissue injuries. PAIN 1998;77:253–60.
    1. Tait RC, Pollard CA, Margolis RB, Duckro PN, Krause SJ. The pain disability index: psychometric and validity data. Arch Phys Med Rehabil 1987;68:438–41.
    1. Wasan AD, Michna E, Edwards RR, Katz JN, Nedeljkovic SS, Dolman AJ, Jamison RN. Psychiatric comorbidity is associated prospectively with diminished opioid analgesia and increased opioid misuse in patients with chronic low back pain. Anesthesiology 2015;132:861–72.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir